// App-Quantinova.ai

: Plasma Extracellular Vesicle-Associated microRNAs for Early Response Prediction in Patients with High-Grade B-Cell Lymphoma

Researchers

Presenter

  • Steven Wang

Principal Investigators

  • Cristina Gómez-Martín

  • A. De Jonge

  • Monique van Eijndhoven

  • Nils Groenewegen

  • Sandra Veldt-Verkuijlen

  • Marcel Nijland

  • Marjolein W.M. Van der Poel

  • Yorick Sandberg

  • Rozemarijn Van Rijn

  • Pim Mutsaers

  • Vibeke K.J. Vergote

  • Marie Jose Kersten

  • Yavuz M. Bilgin

  • Wendy B.C. Stevens

  • Marc Durian

  • Tjeerd J.F. Snijders

  • Daphne de Jong

  • Josée M. Zijlstra

  • Martine E.D. Chamuleau

  • Dirk Michiel Pegtel

Medical Centers

  • Department of Pathology, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, Netherlands

  • Department of Hematology, University Hospitals Leuven, Leuven, Belgium

  • Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands

  • University Medical Center Groningen, Groningen, Netherlands

  • Department of Hematology, Radboud university medical center, Nijmegen, Netherlands

  • Department of Internal Medicine, Maasstad Hospital, Rotterdam, Netherlands

  • Department of Hematology, Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands

  • Exbiome B.V., Amsterdam, Netherlands

  • Department of Hematology, Maastricht University Medical Center, Maastricht, Netherlands

  • Medical Center Leeuwarden, Leeuwarden, Netherlands

  • Medisch Spectrum Twente, Enschede, Netherlands

  • Department of Hematology, St Elisabeth Hospital, Tilburg, Netherlands

  • Department of Internal Medicine, Admiraal de Ruijter Hospital, Goes, Netherlands

Locations

  • Netherlands

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • B cell lymphomas

Biomarkers

  • N/A

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Vincristine

  • Doxorubicin

  • Prednisone

  • Etoposide

  • Etoposide phosphate

  • Nivolumab

  • Rituximab

Outcome

  • N/A


Study Design

  • Randomized

  • Multicenteric

  • Prospective

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A